
Almirall SA
Madrid-ibex
Almirall SA (ALMxmad) is a Spanish specialty pharmaceutical company headquartered in Barcelona. The company focuses on the development, manufacturing, and commercialization of dermatology products, including treatments for psoriasis, atopic dermatitis, and acne. Key products include Ilumetri (tildrakizumab) and Klisyri (tirbanibulin). Almirall operates across Europe and in the United States. It is listed on Bolsa de Madrid. The company is a leading European dermatology-focused pharmaceutical company with a growing pipeline of specialty skin treatments.
Start trading
Almirall SA now
At In2Markets, we offer unique strategies designed to align with your goals and adapt to changing market conditions. Our team will provide you with real-time support and expert insights to answer your question in a quick and personal way. Whether you’re trading or managing your portfolio, we combine innovation with a personalized approach to ensure you stay ahead.
.png?width=2000&height=1471&name=Update%20I2M%20Telefoon%20(1).png)